D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 85 Citations 45,258 353 World Ranking 218 National Ranking 107
Medicine D-index 105 Citations 57,416 621 World Ranking 3035 National Ranking 1752

Research.com Recognitions

Awards & Achievements

2015 - Fellow of the Royal Society of New Zealand

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Asthma
  • Disease

Richard Beasley focuses on Asthma, Internal medicine, Pediatrics, Epidemiology and Allergy. His Asthma research is mostly focused on the topic Atopy. The Internal medicine study combines topics in areas such as Placebo and Anesthesia.

His studies deal with areas such as Wheeze, Body mass index, Obesity, Cross-sectional study and Asthma symptoms as well as Pediatrics. His Epidemiology study which covers Global health that intersects with Family medicine and Asthma mortality. His Allergy research is multidisciplinary, incorporating elements of Etiology and Environmental health.

His most cited work include:

  • Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC (2889 citations)
  • International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. (2693 citations)
  • The global burden of asthma: executive summary of the GINA Dissemination Committee Report (2657 citations)

What are the main themes of his work throughout his whole career to date?

Richard Beasley mainly investigates Asthma, Internal medicine, Anesthesia, Intensive care medicine and Randomized controlled trial. His study brings together the fields of Pediatrics and Asthma. Richard Beasley focuses mostly in the field of Pediatrics, narrowing it down to topics relating to Epidemiology and, in certain cases, Public health.

The concepts of his Internal medicine study are interwoven with issues in Gastroenterology and Surgery. His Anesthesia research incorporates themes from Crossover study, Metered-dose inhaler and Bronchodilator. His Randomized controlled trial study combines topics from a wide range of disciplines, such as Physical therapy and Clinical trial.

He most often published in these fields:

  • Asthma (65.87%)
  • Internal medicine (35.47%)
  • Anesthesia (22.13%)

What were the highlights of his more recent work (between 2015-2021)?

  • Asthma (65.87%)
  • Internal medicine (35.47%)
  • Randomized controlled trial (20.27%)

In recent papers he was focusing on the following fields of study:

His main research concerns Asthma, Internal medicine, Randomized controlled trial, COPD and Intensive care medicine. His study on Budesonide is often connected to Periostin as part of broader study in Asthma. Richard Beasley combines subjects such as Gastroenterology and Placebo with his study of Internal medicine.

The study incorporates disciplines such as Regimen, Anesthesia, Mild asthma and Physical therapy in addition to Randomized controlled trial. His COPD research also works with subjects such as

  • Oxygen saturation that connect with fields like Pulse oximetry,
  • Oxygen therapy that connect with fields like Emergency medicine, Interquartile range and Intensive care unit. Richard Beasley interconnects Guideline and Asthma severity in the investigation of issues within Intensive care medicine.

Between 2015 and 2021, his most popular works were:

  • Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial (555 citations)
  • Treatable traits: toward precision medicine of chronic airway diseases. (420 citations)
  • After asthma: redefining airways diseases (390 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Disease
  • Asthma

Richard Beasley mostly deals with Asthma, Internal medicine, Randomized controlled trial, Periostin and COPD. In the subject of general Asthma, his work in Budesonide is often linked to Exhaled nitric oxide, thereby combining diverse domains of study. The various areas that he examines in his Internal medicine study include Gastroenterology and Inhalation.

His work carried out in the field of Randomized controlled trial brings together such families of science as Oxygen therapy, Placebo, Crossover study and Adverse effect. His Crossover study research is multidisciplinary, incorporating perspectives in Anesthesia and Stress ulcer. His study looks at the intersection of Allergy and topics like Environmental health with Cross-sectional study.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

The global burden of asthma: executive summary of the GINA Dissemination Committee Report

Matthew Masoli;Denise Fabian;Shaun Holt;Richard Beasley.
Allergy (2004)

4955 Citations

International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods.

M. I. Asher;U. Keil;H. R. Anderson;R. Beasley.
European Respiratory Journal (1995)

3830 Citations

Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC

Richard Beasley.
The Lancet (1998)

2907 Citations

Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee.

R Beasley;N Pearce;E Von Mutius.
The Lancet (1998)

2346 Citations

Cellular events in the bronchi in mild asthma and after bronchial provocation.

Richard Beasley;William R. Roche;J. Alan Roberts;Stephen T. Holgate.
The American review of respiratory disease (1989)

1411 Citations

Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC)

Neil Pearce;Nadia Aït-Khaled;Richard Beasley;Javier Mallol.
Thorax (2007)

1387 Citations

SUBEPITHELIAL FIBROSIS IN THE BRONCHI OF ASTHMATICS

WilliamR. Roche;JulieH. Williams;Richard Beasley;StephenT. Holgate.
The Lancet (1989)

1352 Citations

Benefits of omalizumab as add‐on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE

M. Humbert;R. Beasley;J. Ayres;R. Slavin.
Allergy (2005)

1313 Citations

Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood.

Hywel Williams;Colin Robertson;Alistair Stewart;Nadia Aït-Khaled.
The Journal of Allergy and Clinical Immunology (1999)

1213 Citations

Epidemiology and costs of chronic obstructive pulmonary disease.

K R Chapman;D M Mannino;J B Soriano;P A Vermeire.
European Respiratory Journal (2006)

1000 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Richard Beasley

Stephen T. Holgate

Stephen T. Holgate

University of Southampton

Publications: 176

Peter G. Gibson

Peter G. Gibson

University of Newcastle Australia

Publications: 160

Jean Bousquet

Jean Bousquet

Inserm : Institut national de la santé et de la recherche médicale

Publications: 156

Neil Pearce

Neil Pearce

University of London

Publications: 117

David Price

David Price

University of Aberdeen

Publications: 106

Aziz Sheikh

Aziz Sheikh

University of Edinburgh

Publications: 104

Andrew Bush

Andrew Bush

National Institutes of Health

Publications: 101

Bert Brunekreef

Bert Brunekreef

Utrecht University

Publications: 99

Scott T. Weiss

Scott T. Weiss

Harvard University

Publications: 98

Shyamali C. Dharmage

Shyamali C. Dharmage

University of Melbourne

Publications: 91

Paul M. O'Byrne

Paul M. O'Byrne

McMaster University

Publications: 91

Ian D. Pavord

Ian D. Pavord

University of Oxford

Publications: 85

Ulrich Wahn

Ulrich Wahn

Charité - University Medicine Berlin

Publications: 83

Guy B. Marks

Guy B. Marks

University of New South Wales

Publications: 80

Kian Fan Chung

Kian Fan Chung

National Institutes of Health

Publications: 78

Giorgio Walter Canonica

Giorgio Walter Canonica

Humanitas University

Publications: 77

Trending Scientists

Lane A. Hemaspaandra

Lane A. Hemaspaandra

University of Rochester

Eric Chang

Eric Chang

Microsoft (United States)

Hugh J. McDermott

Hugh J. McDermott

University of Melbourne

José M. C. Ribeiro

José M. C. Ribeiro

National Institutes of Health

Paul Berg

Paul Berg

Eli Lilly (United States)

Anna Dornhaus

Anna Dornhaus

University of Arizona

Lin Ma

Lin Ma

Chinese Academy of Sciences

Claude M. Fauquet

Claude M. Fauquet

Donald Danforth Plant Science Center

William G. Carter

William G. Carter

Fred Hutchinson Cancer Research Center

Takeshi Watanabe

Takeshi Watanabe

University of Tokyo

John Ashby

John Ashby

Syngenta (Switzerland)

Brian Lamb

Brian Lamb

Washington State University

William S. Currie

William S. Currie

University of Michigan–Ann Arbor

Lara A. Boyd

Lara A. Boyd

University of British Columbia

Jonathan L. Bramson

Jonathan L. Bramson

McMaster University

Dobromir Dobrev

Dobromir Dobrev

University of Duisburg-Essen

Something went wrong. Please try again later.